Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists | Zendy

Hellas Cena | Zendy; Luca Chiovato | Zendy; Rossella E. Nappi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists

Author(s) -

Hellas Cena,

Luca Chiovato,

Rossella E. Nappi

Publication year - 2020

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/clinem/dgaa285

Subject(s) - polycystic ovary , medicine , infertility , overweight , obesity , endocrinology , insulin resistance , weight loss , context (archaeology) , body mass index , pregnancy , biology , paleontology , genetics

Obesity is responsible for an increased risk of sub-fecundity and infertility. Obese women show poorer reproductive outcomes regardless of the mode of conception, and higher body mass index (BMI) is associated with poorer fertility prognosis. Polycystic ovary syndrome (PCOS) is one of the leading causes of infertility, and many women with PCOS are also overweight or obese.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research